Purpose

This is a multi-center registry that will prospectively collect regulatory compliant data from children and adolescents with migraine. This study will enroll approximately 200 participants from approximately 20 sites and will examine migraine symptoms, therapeutics used, and biomarkers associated with migraine.

Condition

Eligibility

Eligible Ages
Between 4 Years and 17 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 4 to 17 years of age inclusive at the time of enrollment visit - Meets International Classification of Headache Disorders, 3rd edition criteria for migraine with or without aura - Guardian provides informed consent/HIPAA - Participant provides assent if developmentally appropriate and required by the institutional review board

Exclusion Criteria

  • Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Children and adolescents Children and adolescents between the ages of 4 and 17 years old (inclusive)

More Details

Status
Completed
Sponsor
Duke University

Study Contact

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.